Novartis AG
SIX:NOVNEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVNEE
|
CH |
|
F
|
First Tin PLC
LSE:1SN
|
UK |
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
Multiples-Based Value
The Multiples-Based Value for
Novartis AG (NOVNEE) under the Base Case is 83.7 CHF.
Compared with the current market price of 82.5 CHF, the stock appears
Undervalued by 1% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.